GC68722
Bamlanivimab
Bamlanivimab (Anti-Human SARS-CoV-2) was the first COVID-19 monoclonal antibody (mAb) to receive emergency use authorization (EUA) from the US Food and Drug Administration (FDA) in November 2020· However, due to increasing resistance of the SARS-CoV-2 virus variants to Bamlanivimab, it was revoked in April 2021
ChemicalCAS2423943-37-5
- CAS number
- 2423943-37-5
- Molecular weight
- —
- Formula
- —
- Catalogue number
- GC68722
- Brand
- GLPBIO
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il